EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY).

Bibliographic Details
Corporate Author:	United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families (Author)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. Government Publishing Office, 2018.
Series:	S. hrg. ; 114-805
Subjects:	Prescription pricing > United States. Drugs > Law and legislation > United States. Pharmaceutical industry > United States. Competition > United States. Drug delivery devices > Prices > United States. Legislative hearings.
Online Access:	https://purl.fdlp.gov/GPO/gpo113215

Available Online